|Articles|February 9, 2022
Retrofit Pharmaceutical Equipment for High Containment and Reduced Risk of Cross Contamination
Author(s)ILC Dover
With the growth of highly potent active pharmaceutical ingredients (HPAPIs) and multiple-use facilities that must protect against product cross contamination, the need for engineering controls to achieve high containment has become more critical.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
2
New Targets for Clinical Trials in the European Union
3
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
4
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
5
